BET Inhibition Improves NASH and Liver Fibrosis
https://www.nature.com/articles/s41598-018-35653-4
This study was in mice and used a pan-BET inhibitor from GSK GSK1210151A (I-BET151). Mice were treated with the BET inhibitor for 3 weeks. Encouraging results. Too bad they didn't try the BD-2 selective apabetalone in this study.
BearDownAZ